Please login to the form below

Not currently logged in
Email:
Password:

baricitinib

This page shows the latest baricitinib news and features for those working in and with pharma, biotech and healthcare.

Researchers use AI to identify drugs that could be repurposed for Alzheimer’s

Researchers use AI to identify drugs that could be repurposed for Alzheimer’s

One of the drugs identified using the DRIAD method was Eli Lilly’s Olumiant(baricitinib), which will be investigated in a clinical trial for patients with subjective cognitive complaints, mild cognitive

Latest news

More from news
Approximately 10 fully matching, plus 39 partially matching documents found.

Latest Intelligence

  • NICE – but not enough NICE – but not enough

    A great illustration of why this is unfortunately a myth can be seen in Figure 1, which charts the formulary adoption of Olumiant (baricitinib) – Lilly’s once-daily pill for moderate

  • AI: the smart money is on the smart thinking AI: the smart money is on the smart thinking

    Take, for example, the case of baricitinib, originally an Eli Lilly rheumatoid arthritis drug, now repurposed as a promising treatment for COVID-19.

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    Lilly’s already-approved Olumiant (baricitinib) and Pfizer’s PF-04965842 are rivals for Abbvie’s upadacitinib, but Gilead and Galapagos’ filgotinib (an AbbVie cast-off) now looks like the biggest

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

The biggest problems facing humanity today are health-related, and the health of people, animals and our planet are inextricably linked. ...

Latest intelligence

DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...

Infographics